Supplementary Figures from A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis by Bo Kyung A. Seong (14926620)

“…Supplementary Figure 4 - CADM1 over-expression decreases migration of SHEP cell line. Supplementary Figure 5 - Verteporfin (VP), a pharmacological inhibitor of YAP, induces apoptosis and decreases migration of metastatic cells in in vitro and inhibits the metastatic phenotype in vivo. …”

Effects of huperzine A on hippocampal inflammatory response and neurotrophic factors in aged rats after anesthesia by Yi Cai (233861)

“…Conclusion HupA may alleviate the cognitive impairment in rats after isoflurane anesthesia by decreasing inflammatory factors and increasing hippocampal neurotrophic factors in hippocampus tissue.…”

Calibrated curve assuming a normal distribution, using bchron in R, and histogram of temple dates. by Sarah Klassen (5931605)

Image_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_7_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_8_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_4_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_2_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_6_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Table 1_Ferula (Ferula elaeochytris) as a phytoestrogen: Use of Ferula in laying hens.docx by Arda Onur Özkök (20595461)

“…FRP-1 and FRP-2 groups, however, were fed a diet supplemented with 1 g/kg and 2 g/kg FRP, respectively. …”

Table_5_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

“…Background<p>Myelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS. …”

Image_4_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.PNG by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Image_5_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

Image_3_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

“…Here, we propose the surprise-sensitive utility model, a reinforcement learning model that states that surprise decreases the outcome value, to explain how surprise affects subsequent decision making. …”

A. IP₃ receptors lateral mobility in ER patches and reticular ER. by Lu Sun (194355)

“…As IP₃ receptor cluster size increases the delay in response to an IP₃ pulse decreases. <b>C.</b> Modeling Ca²⁺ release spatial and amplitude distribution from two IP₃ receptor clusters of varying size (20 and 1000) in response to a sub-threshold IP₃ pulse. …”

Reversion of pH-Induced Physiological Drug Resistance: A Novel Function of Copolymeric Nanoparticles by Rutian Li (203852)

“…Weakly basic anticancer drugs will be protonated extracellularly and display a decreased intracellular concentration. In this study, we show that copolymeric nanoparticles (NPs) are able to overcome this “pH-induced physiological drug resistance” (PIPDR) by delivering drugs to the cancer cells via endocytosis rather than passive diffussion.…”